{"entity":{"type":"insider","cik":"0001288233","url":"/insider/0001288233","json_url":"/insider/0001288233.json","name":"GOLD DANIEL P PHD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":1,"n_filings":1,"first":"2019-12-20","last":"2019-12-20","span_basis":"filed_date"},"name_variants":[{"name":"GOLD DANIEL P PHD","source":"filing","n_filings":1,"first_seen":"2019-12-20","last_seen":"2019-12-20"}],"transactions":[{"id":8420484,"accession":"0001209191-19-061469","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-061469","line_url":"/filing/0001209191-19-061469#line-1","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":"0001288233","owner_name":"GOLD DANIEL P PHD","owner_display_name":"GOLD DANIEL P PHD","owner_url":"/insider/0001288233","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18750.0,"shares_display":"18,750","price_per_share":1.6,"price_display":"1.60","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":361632.0,"shares_owned_after_display":"361,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-19","filed_date":"2019-12-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001262104","name":"MEI Pharma, Inc.","url":"/issuer/0001262104","role":"Director, Officer (Chief Executive Officer)","n_filings":1,"first_seen":"2019-12-20","last_seen":"2019-12-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001288233","retrieved_at":"2026-08-22T19:55:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}